Monday, November 3, 2014

Top 5 Heal Care Companies To Invest In 2014

Emerging markets have heated up for every industry, but the world's biggest pharmaceutical players have approached the challenges of capturing these promising markets in unique ways. Generic competition spawned by loose legal frameworks and a lack of solid middle-class wealth has hampered big pharma's push into some of the world's top developing economies, but the industry's top companies can't afford to miss out on this hundred-billion dollar opportunity in the making.

Sales around the pharmaceutical industry have been falling because of patent losses, and untapped emerging markets represent one last low-hanging frontier for the sector. Can big pharma take advantage of the world's fast-growing developing nations -- and are China, India, and other emerging economies even ready for the industry's entrance? Motley Fool contributor Dan Carroll and health care analyst Max Macaluso discuss below what you need to know about big pharma's battle to win the emerging markets.

Hot Value Stocks To Invest In 2015: Spdr Kbw Regional Banking (KRE)

SPDR KBW Regional Banking ETF (the Fund), formerly KBW Regional Banking ETF, is a non-diversified investment company. The Fund seeks to replicate as closely as possible the performance of the KBW Regional Banking Index (the Index). The Fund has entered into an investment advisory agreement with SSgA Funds Management, Inc.

The Regional Banking Index is an equal weighted index of geographically diverse companies representing regional banking institutions listed on the United States stock markets. It is created and maintained by Keefe, Bruyette & Woods, Inc.

Advisors' Opinion:
  • [By Charley Blaine]

    The Financial Select Sector SPDR (NYSE: XLF) exchange-traded fund is up 4.86%, tops among ETFs that mimic the sectors of the S&P 500. The SPDR S&P Regional Banking ETF (NYSE: KRE) is up 7.1 percent this month.

Top 5 Heal Care Companies To Invest In 2014: C.R. Bard Inc. (BCR)

C. R. Bard, Inc., together with its subsidiaries, engages in the design, manufacture, packaging, distribution, and sale of medical, surgical, diagnostic, and patient care devices worldwide. It offers vascular, urology, oncology, and surgical specialty products. The company?s vascular products include percutaneous transluminal angioplasty catheters, chronic total occlusions catheters, guidewires, introducers, and accessories; peripheral vascular stents and stent grafts, vena cava filters, and biopsy devices; electrophysiology products, such as electrophysiology laboratory systems and diagnostic, therapeutic, and temporary pacing electrode catheters; and fabrics, meshes, and implantable vascular grafts. Its urology products comprise infection control Foley catheters to reduce the rate of urinary tract infections; surgical slings to treat stress urinary incontinence; fecal incontinence products; natural and synthetic devices to treat pelvic floor and vaginal prolapse; brachyt herapy services, devices, and radioactive seeds to treat prostate cancer; intermittent urinary drainage catheters, and urine monitoring and collection systems; ureteral stents; specialty devices for ureteroscopic procedures and stone removal; and catheter stabilization devices. The company?s oncology products consist of specialty vascular access catheters and ports, vascular access ultrasound devices, dialysis access catheters, and enteral feeding devices to treat and manage various cancers, and other diseases and disorders. Its surgical specialty products include implanted patches and fixation systems for hernia and other soft tissue repairs; irrigation devices for orthopedic, laparoscopic, and gynecological procedures; and products for topical hemostasis. C. R. Bard sells its products directly and through distributors to hospitals, individual health care professionals, extended care facilities, and alternate site facilities. The company was founded in 1907 and is based in Murray Hill, New Jersey.

Advisors' Opinion:
  • [By Eric Volkman]

    Boston Scientific (NYSE: BSX  ) has made a strong move deeper into the business of electrophysiology -- the study of electrical phemomena, and how they are related to the functions of the body. The company announced�that it inked an agreement to purchase Bard EP, the electrophysiology division of C.R. Bard (NYSE: BCR  ) . The price is $275 million in cash.

Top 5 Heal Care Companies To Invest In 2014: LG Display Co Ltd (LPL)

LG Display Co., Ltd. (LG Display), incorporated in 1985, manufactures thin-film transistor liquid crystal display (TFT-LCD) panels in a range of sizes and specifications primarily for use in televisions, notebook computers and desktop monitors, and the Company is a suppliers of high-definition television panels. The Company also manufactures TFT-LCDs for other application products, such as mobile phones, certain types of tablet personal computers and industrial and other applications, including entertainment systems, automotives, portable navigation devices, e-books, digital photo displays and medical diagnostic equipment. During the year ended December 31, 2010, LG Display sold a total of 160.4 million large-size (nine-inch or larger) TFT-LCD panels. In addition to TFT-LCD panels, the Company also manufactures organic light-emitting diode (OLEDs) and flexible displays. As of March 31, 2011, the Company held a total of 15,049 patents, including 6,724 in Korea and 8,325 in other countries, including in the United States, China, Japan, Germany, France, Great Britain and Taiwan.

In May 2010, the Company purchased the liquid crystal display module division of LG Innotek Co., Ltd. (LG Innotek), a subsidiary of LG Electronics. In June 2010, the Company entered into a joint venture agreement with Iriver Ltd. to establish L&I Electronic Technology (Dongguan) Ltd. in Dongguan, China. In August 2010, the Company entered into a joint venture agreement with Everlight Electronics Co., Ltd. and AmTRAN Technology Co., Ltd., to establish Eralite Optoelectronics (Jiangsu) Co., Ltd.

As of December 31, 2010, the Company operated 12 panel fabrication facilities (five in Paju, Korea and seven in Gumi, Korea, and including expansions of certain facilities) and a total of nine module facilities (three in Nanjing, China, two in Guangzhou, China and one each in Gumi and Paju, Korea, Yantai, China and Wroclaw, Poland). In 2010, its display panels were included in products sold by LG Electronics, Appl! e, Toshiba, Dell, Hewlett-Packard, Philips Electronics.

Televisions

The Company�� television panels range from 15 inches to 72-inch wide-format in size. The Company�� product portfolio includes panels of various sizes, such as 17-inch, 19-inch, 20-inch, 22-inch, 26-inch, 32-inch, 37-inch, 42-inch, 47-inch and 55-inch panels.As of december 31, 2010, 32-inch, 37-inch, 42-inch and 47-inch wide-format panels consists of principal products in this category in terms of sales revenue and sales volume.

Desktop Monitors

The Company�� desktop monitor display panels range from 15 inches to 30-inch wide-format in size in a variety of display resolutions and formats. In 2010, 19-inch and 21.5-inch display panels were its principal products in terms of sales revenue and sales volume in this category.

Notebook Computers

The Company�� display panels for notebook computers range from seven inches to 20.1-inch wide-format in size in a variety of display formats. In 2010, 15.6-inch, 9.7-inch and 14-inch panels were its principal products in this category.

Mobile and Other Applications

The Company�� product portfolio also includes panels for mobile and other applications, which utilize a wide array of display panel sizes, including mobile phones, certain types of tablet personal computers and industrial and other applications, including entertainment systems, automotives, portable navigation devices, e-books, digital photo displays and medical diagnostic equipment. TFT-LCD panels that are nine inches and smaller are referred to as small and medium-size panels, with those smaller than four inches being considered small-size panels. In 2010, sales of small-size panels constituted a significant majority in terms of both sales revenue and sales volume in the mobile and other applications category. Some of the panels the Company produces for industrial products, such as medical diagnostic equipment.

T! he Compan! y competes with Samsung Electronics, Samsung Mobile Display and Hydis Technologies, AU Optronics, Chimei Innolux, Chunghwa Picture Tubes, HannStar, Sharp, Hitachi, TMDisplay, Mitsubishi, IPS-Alpha, SAVIC, Infovision and BOE-OT.

Advisors' Opinion:
  • [By Steve Symington]

    Naturally, that spooked investors in Universal Display (NASDAQ: OLED  ) , the company whose technology enables nearly every OLED device on the market today. Even so, I noted that Cook's comments seemed curious at the time, especially given that recent reports claimed Apple had just hired a senior OLED technology expert away from one of its primary screen suppliers in LG Display (NYSE: LPL  ) .

Top 5 Heal Care Companies To Invest In 2014: OriginOil Inc (OOIL)

OriginOil, Inc., incorporated on June 1, 2007, is a technology company. The Company is primarily involved in research and development activities, and sales of pilot and demonstration equipment. The Company has developed an energy production process for harvesting algae and cleaning up oil and gas water. To develop the energy and ancillary markets, the Company sells smaller-scale equipment, such as the Algae Appliance. The Company�� process, CLEAN-FRAC, represents a generation of water treatment that is chemical free. The Company's water cleanup technology, Electro Water Separation (EWS), is a chemical-free process that extracts organic contaminants from large quantities of water. Its products include EWS Algae, EWS Algae A4, EWS Algae A60, EWS Algae A200, EWS Petro P160, and EWS Aqua Q60.

The Company intends to embed its technology into larger systems through licensing and joint ventures. The Company is in the process of pursuing secondary licensing opportunities outside of energy, including aquaculture. EWS Algae A4 is an entry-level algae harvester designed to make it easier and faster for producers and researchers to try and buy the Company's harvesting technology. EWS Algae A60 is a pilot scale algae harvester providing a low energy, chemical-free, continuous flow wet harvest system to dewater and concentrate the microalgae. EWS Petro Model 160 is designed to remove organics, such as crude oil, and suspended solids and bacteria from process water, such as produced or frac flowback water at a continuous flow rate of one barrel per minute or 160 liters per minute in continuous, chemical free operation. EWS Aqua Q60 is a commercial fish farming pond water treatment system, designed to clean pond water of ammonia, bacteria and aquatic animal pathogens in a continuous loop.

Advisors' Opinion:
  • [By CRWE]

    Today, OOIL�has shed (-3.12%) down -0.01 at $.31 with 95,929 shares in play thus far (ref. google finance Delayed: 2:04PM�EDT October 15, 2013).

    OriginOil, Inc. previously reported it has signed its first pay-per-barrel agreement with Industrial Systems, Inc. (ISI) for a water treatment system integrating OriginOil�� process as the first stage of treatment.

    Delta, Colorado-based ISI has agreed that it will operate the Model P160 as part of its overall frac flowback water cleanup service, and pay OriginOil a fee for each barrel processed.

No comments:

Post a Comment